Press Releases

Stability Screening Meets Tetravalent Bispecifics In Next Generation Collaboration

Protein Stable, a joint venture between Applied Photophysics and Fluorescence Innovations, has announced a collaboration with F-star Therapeutics, a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm shift in cancer therapy

Optima Laboratory Resource Management System V2021.1 Software Release Announcement

Optima, a software company aiming to provide solutions to address laboratory resource management challenges, has announced the new Optima Laboratory Resource Management System — LRMS version 2021.1.

Nottingham University Hospitals NHS Trust selects Indica Labs to deliver their Digital Pathology Solution with HALO AP®

Nottingham University Hospitals (NUH) NHS Trust, has announced the selection of Indica Labs, the world’s leading provider of computational pathology software and services, to aid in full digitisation of the pathology workflow.

The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses

Dear Nicole, Immudex ApS, a pioneering life science company spearheading the global adoption of precision immune monitoring, has announced the launch of the new U-Load Dextramer® product line.

Shimmer Adopts the V3 Framework to Validate its Verisense® Wearable Sensing Platform for Clinical Trials

The Verisense IMU (inertial measurement unit) was the first Shimmer sensor validated following the V3 framework championed by the Digital Medicine Society (DiMe).

BOC Sciences Provides High-quality Raw Materials to Accelerate mRNA Vaccine Supply

Takara Bio enters into a license and supply agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH

Takara Bio Inc. has announced that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech").

IntegrateRNA Develops Customized CircRNA Pull-down Detection Service to Identify The Interaction Between miRNA/RBP and circRNA

Microbiosci Releases Optimized Real-time PCR Kits for RNA detection and Gene Sequencing

Creative Biogene Provides Microbial Sequencing Services and Solutions to Support Sequencing and Bioinformatics Analysis

BioIVT Acquires Serum, Plasma and Reagent Producer and IVD Manufacturer Valley Biomedical Products & Services

This transaction will expand BioIVT’s in vitro diagnostic, cell and gene therapy support capabilities.

Different Surface Nanopattering Techniques are Available Now at Matexcel

The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial

SCOHIA PHARMA, a drug discovery bioventure focusing on the field of lifestyle-related diseases such as cardiovascular, metabolic, and renal diseases has announced the results of a phase 1 clinical trial for SCO-267, an orally bioavailable GPR40 full agonist, at the Virtual 81st Scientific Sessions - American Diabetes Association, June 25-29, 2021.

Creative Biostructure Enables Exosome Isolation and Purification for Various Samples

Profacgen Provides an Ultimate Solution of Animal-free Protein Production Services for Research Needs

AARDEX Group and AdhereTech Partnership Boosts Medication Adherence with Software, Data Analytics and Smart Pill Bottle

Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with AdhereTech, an innovative company that improves the patient experience with real-time technology and Smart devices for optimal medication benefits.

CluePoints’ Launch Post-COVID Trial Assurance Solution

CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission to build safer, more efficient trials for patients, sponsors and CROs.

4G Clinical Announces $230MM Growth Equity Investment Backed by Goldman Sachs Asset Management

4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, announced it has entered into an agreement to receive a growth equity investment of over $230MM from Goldman Sachs Asset Management ("Goldman Sachs"). The investment will be used to fund 4G Clinical's continued global expansion, support the growing demand for 4G's products, and to further the company's mission of bringing crucial medicines to those who need them, faster.

Isohelix and AutoGen sign a collaborative supply agreement

Isohelix, a specialist provider of DNA and RNA sampling and purification products, and AutoGen, Inc., a leading provider of nucleic acid extraction automation, have signed a far-reaching supply agreement.

GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent

GenNext Technologies, Inc., a growth-stage company that provides instrumentation, software and services to structural biology researchers within the biopharmaceutical industry, announced today that nearly $7M (US) in NIH grant awards has led to a seminal US patent for its novel technology.